Articles with the topic: clinical-trial

Dimebon fails in late-stage human HD clinical trial

Dimebon fails to improve symptoms in HD patients in the HORIZON trial

Dr Jeff Carroll | April 11, 2011

FDA: further trial needed for Huntexil approval in HD

Bad news for Huntexil – the FDA requires another trial before it can be approved in the US

Dr Jeff Carroll | April 04, 2011

Successful gene therapy trial in Parkinson’s Disease gives hope for HD

Success for brain ‘gene therapy’ in Parkinson’s disease – good news for similar treatments being developed in HD

Dr Jeff Carroll | March 31, 2011

Dimebon: disappointing in Alzheimer’s but might work in HD

Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.

Dr Jeff Carroll | December 23, 2010

Huntexil for symptoms of Huntington's disease: where are we now?

Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex

Professor Ed Wild | November 16, 2010

Minocycline: the end of the road?

DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.

Professor Ed Wild | November 10, 2010

Start here

New to HD research? Click here to get an overview

Donate

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community.

With your support, we can ensure the continuity of our services. Nothing is expected, but everything is appreciated and sustains what we do at HDBuzz. Please consider giving what you're able. More information...